Leonard Zemel
Endocrinology, Diabetes & Metabolism · Denver, CONPI 1447256045
Payments from drug & device makers
$727,602in general payments, 2019–2025
Across 2,436 payments — averaging $298.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk AS$409K
- AbbVie$171K
- Gilead$44K
- AstraZeneca$43K
- Boehringer Ingelheim$35K
- Boehringer Ingelheim Pharma GmbH & Co.kg$5K
- plus $19K from 36 others
General payments by program year
19
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$727,602 in reported general payments places this provider in the 90th percentile of 120 endocrinology, diabetes & metabolism providers in Colorado.
See all endocrinology, diabetes & metabolism providers in Colorado →
Other endocrinology, diabetes & metabolism in Denver
- Daniel BessesenDenver$1.2M
- Joshua KlopperDenver$48K
- Michael LoughnerDenver$32K
- Alex GoldsmithDenver$12K
- Daniel CitronDenver$8K
- Sarah BullDenver$4K
- Leslie GamacheDenver$4K
- Claudia PanzerDenver$3K
- Sheila MaierDenver$2K
- Karin HickeyDenver$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.